Evidence map›Paper›PMID 40182334›Full record

ArticleCureus2025

Duodenal Bulb Adenocarcinoma: A Case Report.

Mohammad N Kloub, Abdul-Rahman I Abusalim, Abdelhadi Farouji, Mohamed Eldesouki, Atheer Anwar, Raed Atiyat, Mehul Shah

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad N KloubInternal Medicine, Saint Michael's Medical Center, Newark, USA.
Abdul-Rahman I AbusalimInternal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Abdelhadi FaroujiInternal Medicine, Saint Michael's Medical Center, Newark, USA.
Mohamed EldesoukiInternal Medicine, Saint Michael's Medical Center, Newark, USA.
Atheer AnwarSchool of Medicine, Mutah University, Karak, JOR.
Raed AtiyatGastroenterology and Hepatology, Saint Michael's Medical Center, Newark, USA.
Mehul ShahGastroenterology and Hepatology, Saint Michael's Medical Center, Newark, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The duodenum is thought to be the most prevalent site of primary small bowel adenocarcinoma, and the disease mostly affects the descending part of the duodenum. Although the majority of small intestine adenocarcinomas are caused by duodenal adenocarcinomas, it is extremely uncommon for them to occur in the duodenal bulb. We report the case of an 80-year-old female with a complex medical history who presented with symptomatic anemia secondary to gastrointestinal (GI) blood loss secondary to adenocarcinoma of the duodenal bulb.

Indexed as

adenocarcinomaduodenal bulbduodenal cancergastrointestinal cancer surgeryprimary small bowel cancer

Identifiers

PMID40182334
PMCPMC11965774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.